参考文献

1.丰有吉, 沈铿. 妇产科学. 北京: 人民卫生出版社, 2010.

2.Merkow LP. Ultrastructure of an interstitial (hilar) cell tumor of the ovary. Obstet Gynecol, 1971, 37: 845-859.

3.王世阆. 卵巢疾病. 北京: 人民卫生出版社, 2003.

4.范嫏娣. 卵巢临床与病理. 天津: 天津科学技术出版社, 1993.

5.石一复. 郝敏. 卵巢疾病. 北京: 人民军医出版社, 2014.

6.曹云霞. 人类生育力保存. 北京: 人民卫生出版社, 2015.

7.姚泰. 生理学. 北京; 人民卫生出版社, 2005.

8.Clement PB. Histology of the ovary. Am J Surg Pathol, 1987, 11 (4): 277.

9.Baker TG, Franchi LL. The fine structure of oogonia and oocytes in human ovaries. J Cell SCI, 1967, 2: 213.

10.Jahara S, Christenson LK, Wang CY, et al. Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. J Clin Endocrinol Metab, 2003, 88: 484-492.

11.Parr EL. Histological examination of the rat ovarian follicle wall prior to ovulation. Biol Reprod, 1974, 11:483-503.

12.Shinohara H, Nakatani T, Monsawa S, et al. Mast cells in the ovarian bursa of the golden hamser. Biol Reprod, 1974, 11: 483-503.

13.Nakamura Y, Smith M, Kristina A, et al. Increased number of mast cells in the dominant follicle of the cow: Relationship amony luteal, stromal, and hilar regions. Biol Reprod, 1987, 37: 546-549.

14.Owman C, Rosembren E, Sjoberg NO. Adrenergic innervation of the human female reproductive organs. A histological and chemical investigation. Obstet Gynecol, 1967, 30: 763-773.

15.Moshin S, Pennefather JN. The sympathetic innervation of the mammalian ovary, a review of pharmacological and histological studies. Clin Exp Pharmacol Physiol, 1979, 6: 335.

16.Neilson D. The innervation of the ovary. Obstet Gynecol Surv, 1970, 25: 889.

17.Durlinger AL, Kramer P, Karels B, et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology, 1999, 140: 5789-5796.

18.Durling AL, Visser JA, Themmen AP. Regulation of ovarian function: The role of anti-Mullerian hormone. Reproduction, 2002, 124: 601-609.

19.Chun Sy, Billig H, Tilly JL, et al. Gonadotropin suppression of apoptosis in cultured preovulatory follicle: Mediatory role of endogenous insulin-like growth factor I. Endocrinology, 1994, 135: 1845-1854.

20.Chun Sy, Eisenhauer KM, Minaml S, et al. hormonal regulation of apoptosis in early antral follicles: Folliclestimulating hormone as a major survival factor. Endocrinology, 1996, 137: 1447-1456.

21.Automaki K, Luccna JI, Pakrinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell, 1995, 82: 959-968.

22.Choi D, Rohan RM, Rosenfeld RG, et al. Activin-attenuated expression of transcripts encoding granulosa cell-derived insulin-like growth factor binding proteins 4 and 5 in the rat: A putative antiatretic effect. Biol Reprod, 1997, 56: 508-515.

23.Danilovich N, Javeshghani D, Xing W, et al. Endocrine alterations and signaling changes associated with declining ovarian function and advanced biological aging in follicle-stimulating hormone receptor haploinsufficient mice. Biol Reprod, 2002, 67: 370-378.

24.Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev, 2002, 67: 370-378.

25.Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril, 2002, 77: 1170-1177.

26.Filicori M, Cognini GE, Tabarelli C, et al. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab, 2002, 87: 1156-1161.

27.Richards JS, Russell DL, Ochsner S, et al. Ovulation: New dimensions and new regulators of the inflammatory-like response. Annu Rev Physiol, 2002, 64: 69-92.

28.Richardson DW, Goldsmith LJ, Pohl CR, et al. The role of prolactin in the regulation of the primate corpus luteum. J Clin Endocrinol Metab, 1985, 60: 501-504.

29.Knight PG, Glister C. Potential local regulatory functions of inhibins, activins and follistatin in the ovary.Reproduction, 2001, 121: 503-512.

30.de Kretser DM, Hedger MP, Loverland KL, et al. Inhibins, activins and follistatin in reprudction. Hum Reprod Update, 2002, 8: 529-541.

31.Bathgate RAD, Samuel CS, Burazon TCD, et al. Relaxin: New peptides, receptors, and novel actions. Trends Endocrinol Metab, 2003, 14: 207-213.

32.Nilssson EE, Skinner MK. Growth and differentiation factor-9 stimulates progression of early primary but not primordial rat ovarian follicle development. Biol Reprod, 2002, 67: 1018-1024.

33.Wang HS, Chard T. IGFs and IGF-binding r=proteins in the regulation of human ovarian and endometrial function. J Endocrinol, 1999, 161: 1-13.

34.Giudice LC. Insulin-like growth factor family in Graafian follicle development and function. J Soc Gynecol Investig, 2001, 8 (1): 26-29.

35.Eden JA, Jones J, Carter GD, et al. Follicular fluid concentrations of insulin-like growth factor 1, epidermal growth factor, transforming growth factor-alpha and sex steroids in volume-matched normal and polycystic human follicles. Clin Endocrinol, 1990, 32: 395-405.

36.Monget F, Bondy C. Importance of the IGF system in early folliculogenesis. Mol Cell Endocrinol, 2000, 163:89-93.

37.Josso N, di Clemente N, Gouedard L. Anti-Mullerian hormone and its receptors. Mol Cell Endocrinol, 2001,179: 25-32.

38.McGee EA, Smith R, Spears N, et al. Mullerian inhibitory substance induces growth of rat preantral ovarian follicles. Biol Reprod, 2000, 64: 293-298.

39.Nemeth G. The basis and evidence of a role for the ovarian renin-angiotensin system in health and disease. J Soc Gynecol Investig, 1994, 1: 118-127.

40.Schauster KH, Nielsen AH, Winther H, et al. Localization of the renin-angiotensin II receptor expression.Biol Reprod, 2001, 65: 1672-1680.

41.Bennett RA, Osathanondh R, Yeh J. Immunohistochemical localization of transforming growth facor-alpha,epidermal growth factor (EGF), and EGF receptor in the human fetal ovary. J Clin Endocrinol Metab, 1996,81: 3073-3076.

42.Adashi EY. The potential role of interleukin-1 in the ovulatory process: An evolving hypothesis. Mol Cell Endocrinol, 1998, 140: 77-81.

43.Kol S, Ruutiainen, Altman K, Scherzer WJ, et al. The rat intraovarian interleukin (II)-1 system: Cellular localization, cyclic variation and hormonal regulation of IL-1 and of the type I and type II IL-1 receptors. Mol Cell Endocrinol, 1999, 149: 115-128.

44.Grodin JM, Sntern PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab, 1973, 36: 207-214.

45.Dennefors BL, Janson PO, Knulson F, et al. Steroid production and responsiveness to gonadotropin in isolated stromal tissue of human postmenopausal ovaries. Am J Obstet Gynecol, 1980, 136: 997-1002.

46.Lobo RA. Androgens in postmenopausal women: Production, possible role, and replacement options. Obstet Gynecol Surv, 2001, 56: 361-376.

47.Judd HL, Lucas W, Yen SS. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol, 1074, 118: 793-798.

48.Longcope C. Metabolic clearance and blood production rates of estrogens in postmenopausal women. Am J Obstet Gynecol, 1971, 111: 778-781.

49.Mattingly RF, Huang WY. Steroidogenesis of the menopausal and postmenopausal ovary. Am J Obstet Gynecol, 1971, 111: 778-781.

50.Ngamani M, Urban RJ. Expression of messenger ribonucleic acid encoding steroidogenic enzymes in postmenopausal ovaries. J Soc Gynecol Investig, 2003, 10: 37-40.

51.Vermeulen A. The Hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab, 1976, 42:247-253.

52.Greenblatt RB, Colle ML, Mahesh VB. Ovarian and adrenal steroid production in the postmenopausal woman. Obstet Gynecol, 1976, 47: 383-387.

53.Nakano R. Binding sites for gonadotropins in human postmenopausal ovaries. Obstet Gynecol, 1989, 73:196-200.

54.Braithwaite S, Erkman-Balis B, Avila TD. Postmenopausal virilization due to ovarian stromal hyperthecosis.J Clin Endocrinol Metab, 1978, 46: 295-300.

55.Sternberg WH. The morphology, androgenic function, hyperplasia, and tumors of the human ovarian hilus cells. Am J Pathol, 1947, 25: 493.